wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34283336-595B86BB-2769-491A-A14F-77FE072C201B
Q34283336-595B86BB-2769-491A-A14F-77FE072C201B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34283336-595B86BB-2769-491A-A14F-77FE072C201B
Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level.
P2860
Q34283336-595B86BB-2769-491A-A14F-77FE072C201B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34283336-595B86BB-2769-491A-A14F-77FE072C201B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5881cf746d98baef4d786384a62fbfaea5a7e4eb
P2860
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.